MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Retinal Degeneration
    • Skincare
  • News & Media
  • Contact Us
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Retinal Degeneration
    • Skincare
  • News & Media
  • Contact Us
  •  
  • June 2017

AIVITA Comments on Positive Findings from Asterias’ SCiStar Trial for Spinal Cord Injury

AIVITA Biomedical CEO Hans Keirstead, Ph.D. to Speak at Stem Cell Cures Consortium Conference

AIVITA Biomedical is an Irvine, CA based company focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development.

Recent News

  • Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical’s Phase 2 Clinical Trial
  • AIVITA Biomedical Receives Import Approval to Distribute its Professional ROOT of SKIN™ MD Skincare Line in Japan
  • AIVITA Biomedical to Exhibit Skincare Products at ‘The Aesthetic Show’ and ‘AAD Summer Meeting’ in July
  • AIVITA Biomedical Announces New Clinical Data in Ongoing Phase 2 Brain Cancer Trial
  • ROOT OF SKIN™ Skincare Line Sells out in Eighth Consecutive Appearance on QVC Japan

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2017 | AIVITA Biomedical